COX-2 inhibitors delay pancreatic tumor precursors in mice Nimesulide.

The study, in the August 1 problem of Cancer Research published, a journal of the American Association for Cancer Study, suggests a potential role for COX-2 inhibitors in pancreatic cancer prevention among high-risk sufferers.D., scientific director of the Hirshberg Laboratory of Pancreatic Cancer Research and adjunct associate professor at UCLA. Researchers believe pancreatic cancer arises from abnormal cells, or lesions in the pancreas, referred to as pancreatic intraepithelial neoplasias . By stalling the development of PanINs, researchers desire to slow the advancement of or prevent pancreatic cancer tumor. COX-2, an enzyme which in turn causes inflammation, is usually no stranger to malignancy researchers.Related StoriesNew RNA test of blood platelets can be used to identify location of cancerCrucial transformation in single DNA base predisposes children to intense type of cancerOvarian cancer individuals with a history of oral contraceptive make use of have better outcomesCST, a leader in the development and manufacture of powerful antibody products for the medical research and clinical diagnostic markets, discovered the presence of specific variants of EML4-ALK in human cancers and has clinically validated specific antibodies detecting this enzyme in human being cancer tissues from its internal Malignancy Biomarker Program.